title: Pediatric intestinal failure and vascular access.
abstract: Emerging developments in the care of intestinal failure (IF) patients have drastically improved their overall prognosis, with recently reported survival rates over 90%. IF patients remain an extremely complex population who benefit from specialized, multidisciplinary care. Advances in the provision of parenteral and enteral nutrition, progress in the management of IF-associated liver disease with parenteral fish oil and catheter-associated blood stream infection with ethanol lock therapy, and the availability of novel surgical interventions, such as the serial transverse enteroplasty procedure, have made this a dynamic health care field with the promise of ongoing improvements in outcomes for these patients.
authors.affiliation: Department of Surgery and Center for Advanced Intestinal Failure, Children's Hospital Boston and Harvard Medical School, Fegan 3, 300 Longwood Avenue, Boston, MA 02115, USA. biren.modi@childrens.harvard.edu
authors.forename: Biren P
authors.initials: BP
authors.lastname: Modi
authors.forename: Tom
authors.initials: T
authors.lastname: Jaksic
mesh_terms: D055499:Catheter-Related Infections / Q000209:etiology / Q000517:prevention & control; D002405:Catheterization, Central Venous; D002648:Child; D004750:Enteral Nutrition; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007421:Intestine, Small / Q000601:surgery / Q000637:transplantation; D008107:Liver Diseases / Q000209:etiology / Q000517:prevention & control; D008286:Malabsorption Syndromes / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D010288:Parenteral Nutrition; D012778:Short Bowel Syndrome / Q000453:epidemiology / Q000209:etiology / Q000628:therapy
chemical_list: D005765:Gastrointestinal Agents